From Uncertainty to Evidence
Biostatistics that transforms complexity into confident decisions
CLINICAL TRIALS | REAL-WORLD EVIDENCE | STATISTICAL INNOVATION
Rigorous
Methods
Advanced statistical methodology
Regulatory Confidence
Evidence that meets the highest standards
Scientific partnership
Collaborative. Transparent. Impactful
Better
decisions
Turning data into evidence for real-workd impact
Legacy Trials as Latent Assets
Most studies answer one question The data often contain many more >
Multiplicity as a System Property
How many statistical worlds did we explore before arriving at this result? >
From Data Chaos to Regulatory Evidence
Regulators do not approve datasets. They approve evidence >
Subgroup Discover = Subgroup Truth
Not every signal is a treatment effect. Not every pattern is meaningful >
The Trial Ended. The Evidence Journey did not
Trials tell us whether a treatment works. RWE shows how it actually works >
Trial Design
Good evidence starts before the first patient is enrolled.
We support study teams in translating scientific questions into measurable objectives, endpoints, estimands and statistical assumptions that will ultimately support reliable evidence generation.
Next
Legacy Trials
Multiplicity
Real-World Evidence
Legacy Trials
It is a renewable evidence asset.
A completed trial is not an archive.
Meta-analytic shrinkage
Subgroup discovery
External evidence integration
AI-assisted exploration
Therapeutic Area
Study Design
Programming
Reporting
RWE
Advanced Analytics
Oncology
Neurology
Cardiology
Respiratory
Ophthalmology
Gastroenterology
Dermatology
Endocrinology
Infectious Diseases
Vaccines & Immunology
Rare Diseases
Medical Device
Patient Registries